✦ LIBER ✦

Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Dr. Denis Leonardo Fontes Jardim, Débora de Melo Gagliato…

Book ID: 120808050
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2012
Tongue: English
Weight: 163 KB
Volume: 12
Category: Article
ISSN: 1174-5886
DOI: 10.2165/11636760-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib alone or with bevacizumab as f

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

✍ Seto, Takashi; Kato, Terufumi; Nishio, Makoto; Goto, Koichi; Atagi, Shinji; Hoso 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 398 KB

9147 Bevacizumab and erlotinib as first-

9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

First-Line Bevacizumab-Based Therapy in

First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer

✍ Alessandra Bearz, Rodolfo Passalacqua, Oscar Alabiso, Saverio Cinieri, Cesare Gr 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 222 KB

Oxaliplatin in First-line Therapy for Ad

Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer

✍ Luis E. Raez; Svetlana Kobina; Edgardo S. Santos 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 283 KB

Gefitinib as first-line, compassionate u

Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer

✍ Argiris, Athanassios; Mittal, Namrata 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Second-line therapy for advanced non-sma

Second-line therapy for advanced non-small-cell lung cancer

✍ Christine L. Hann; Julie R. Brahmer 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 90 KB